The Discounted Cash Flow (DCF) valuation of Oasmia Pharmaceutical AB (OASM.ST) is (3,557.60) Oasmia Pharmaceutical. With the latest stock price at 1.69 Oasmia Pharmaceutical, the upside of Oasmia Pharmaceutical AB based on DCF is -121935.5%.
Based on the latest price of 1.69 Oasmia Pharmaceutical and our DCF valuation, Oasmia Pharmaceutical AB (OASM.ST) is a sell. selling OASM.ST stocks now will result in a potential gain of 121935.5%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.3% - 9.3% | 7.3% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (40,496.72) - (1,834.11) | (3,557.60) |
| Upside | -1386973.9% - -62911.9% | -121935.5% |